Adenovirus vectors containing cell status-specific response elements and methods of use thereof
View Patent ↗The present invention provides adenoviral vectors comprising cell status-specific transcriptional regulatory elements which confer cell status-specific transcriptional regulation on an adenoviral gene. A “cell status” is generally a reversible physiological and/or environmental state. The invention further provides compositions and host cells comprising the vectors, as well as methods of using the vectors.
1. A replication-competent adenovirus vector for selective cytolysis of a target cell comprising,
a hypoxia responsive element (HRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4, wherein said HRE comprises a binding site for hypoxia inducible factor-1 is activated and the vector effects selective cytolysis of said target cell under hypoxic conditions.
2. The adenovirus vector of claim 1 , wherein the HRE is human.
3. The adenovirus vector of claim 1 , wherein said adenovirus gene essential for replication is operably linked to a composite regulatory element comprising said HRE and a tumor cell-specific transcriptional regulatory element (TRE).
4. The adenovirus vector of claim 3 , wherein said tumor cell-specific TRE comprises a promoter.
5. The adenovirus vector of claim 3 , wherein said tumor cell-specific TRE comprises an enhancer.
6. The adenovirus vector of claim 3 , wherein said tumor cell-specific TRE comprises a prostate specific promoter and enhancer.
7. The adenovirus vector of claim 3 , wherein said tumor cell-specific transcriptional regulatory element (TRE) is selected from the group consisting of a prostate-specific TRE (PSA-TRE), a glandular kallikrein-1 TRE (hKLK2-TRE), a probasin TRE (PB-TRE), an α-fetoprotein TRE (AFP TRE) and a carcinoembryonic antigen TRE (CEA TRE).
8. A composition comprising:
a replication-competent adenovirus vector of claim 1 and a pharmaceutically acceptable excipient.
9. An isolated host cell comprising the adenovirus vector of claim 1 .
10. A method of propagating adenovirus in vitro, the method comprising:
introducing into a cell an adenovirus vector comprising a hypoxia responsive element (HRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4, wherein said HRE comprises a binding site for hypoxia inducible factor-1 wherein said cell is maintained under hypoxic conditions in vitro, thereby expressing said adenovirus gene essential for replication;
wherein said adenovirus is propagated.
11. The method of claim 10 , wherein said propagating of said adenovirus is cytotoxic to said cell.
12. The method of claim 11 , wherein said cell is a tumor cell.
13. A replication-competent adenovirus vector for selective cytolysis of a target cell with a disrupted RB function, comprising:
an E2F-1 transcriptional regulatory element (TRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4, wherein said vector effects selective cytolysis due to selective replication in a target cell with disrupted RB function.
14. The adenovirus vector of claim 13 , wherein the E2F-1 TRE is human.
15. The adenovirus vector of claim 14 , wherein said E2F-1 TRE comprises the nucleotide sequence set forth in SEQ ID NO:2.
16. The adenovirus vector of claim 13 , wherein said E2F-1 TRE comprises a nucleotide sequence having at least 80% sequence identity with the sequence set forth in SEQ ID NO:2.
17. The adenovirus vector of claim 13 , wherein said adenovirus gene essential for replication is operably linked to a composite regulatory element comprising said E2F-1 transcriptional regulatory element and a cell-type specific transcriptional regulatory element (TRE).
18. The adenovirus vector of claim 17 , wherein said tumor cell-specific transcriptional regulatory element (TRE) is selected from the group consisting of a prostate-specific TRE (PSA-TRE), a glandular kallikrein-1 TRE (hKLK2-TRE), a probasin TRE (PB-TRE), an α-fetoprotein TRE (AFP TRE) and a carcinoembryonic antigen TRE (CEA TRE).
19. A composition comprising:
a replication competent adenovirus vector of claim 13 and a pharmaceutically acceptable excipient.
20. An isolated host cell comprising the adenovirus vector of claim 13 .
21. A method of propagating adenovirus in vitro, the method comprising:
a replication competent adenovirus vector for selective cytolysis of a target cell, comprising an E2F-1 transcriptional regulatory element (TRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4 wherein said cell is maintained under cell cycling conditions in vitro, thereby expressing said adenovirus gene essential for replication;
wherein said adenovirus is propagated.
22. The method of claim 21 , wherein said propagating of said adenovirus is cytotoxic to said cell.
23. The method of claim 21 , wherein said cell is a tumor cell.
24. A replication-competent adenovirus vector for selective cytolysis of a target cell comprising,
a hypoxia responsive element (HRE) comprising a binding site for hypoxia inducible factor-1 operably linked to a first adenovirus gene essential for replication and a transcriptional regulatory element (TRE) comprising a heterologous promoter or enhancer operably linked to a second adenoviral gene essential for replication wherein said first and second adenoviral genes essential for replication are selected from the group consisting of E1A, E1B and E4 wherein said adenovirus vector results in cytolysis due to selective replication in a target cell in which a hypoxia inducible factor-1 is present.
25. The replication-competent adenovirus vector of claim 24 , wherein said transcriptional regulatory element (TRE) linked to said second adenoviral gene essential for replication is a cell status-specific transcriptional regulatory element (TRE).
26. The replication-competent adenovirus vector of claim 24 , wherein said transcriptional regulatory element (TRE) linked to said second adenoviral gene essential for replication is a cell type-specific transcriptional regulatory element (TRE).
27. A replication-competent adenovirus vector for selective cytolysis of a target cell, comprising
an E2F-1 transcriptional regulatory element (TRE) operably linked to a first adenovirus gene essential for replication and a transcriptional regulatory element (TRE) comprising a heterologous promoter or enhancer operably linked to a second adenoviral gene essential for replication wherein said first and second adenoviral genes essential for replication are selected from the group consisting of E1A, E1B and E4 wherein said adenovirus vector results in cytolysis due to selective replication in a target cell in which RB function is disrupted.
28. The replication-competent adenovirus vector of claim 27 , wherein said transcriptional regulatory element (TRE) linked to said second adenoviral gene essential for replication is a cell status-specific transcriptional regulatory element (TRE).
29. The replication-competent adenovirus vector of claim 27 , wherein said transcriptional regulatory element (TRE) linked to said second adenoviral gene essential for replication is a cell type-specific transcriptional regulatory element (TRE).
30. A replication-competent adenovirus vector for selective cytolysis of a target cell comprising,
a hypoxia responsive element (HRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4, wherein said HRE comprises a binding site for hypoxia inducible factor-1 wherein target cell, said adenovirus vector results in cytolysis due to selective replication in a tumor cell in which a hypoxia inducible factor-1 is present.
31. A replication-competent adenovirus vector for selective cytolysis of a tumor target cell, comprising:
an E2F-1 transcriptional regulatory element (TRE) operably linked to an adenovirus gene essential for replication selected from the group consisting of E1A, E1B and E4 wherein said adenovirus vector results in cytolysis due to selective replication in a tumor target cell to which E2F-1 is present.